Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Pediatric ALL”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06080191
What this trial is testing

Allogeneic Second-generation CD19-CAR T Cells for Pediatric Relapsed/Refractory B-ALL

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Bambino Gesù Hospital and Research Institute 24
Early research (Phase 1)Looking for participantsNCT03721068
What this trial is testing

Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma

Who this might be right for
NeuroblastomaOsteosarcoma
UNC Lineberger Comprehensive Cancer Center 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT04195555
What this trial is testing

Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Recurrent EpendymomaRecurrent Ewing SarcomaRecurrent Hepatoblastoma+30 more
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT03834961
What this trial is testing

Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia

Who this might be right for
Central Nervous System NeoplasmInfantile FibrosarcomaRecurrent Acute Leukemia+2 more
Children's Oncology Group 33
Early research (Phase 1)Looking for participantsNCT07108868
What this trial is testing

A Phase I Dose Finding Study of MB-CART2219.1

Who this might be right for
LymphomaCLLAcute Lymphoblastic Leukemia, Pediatric
University Hospital Tuebingen 36
Early research (Phase 1)Study completedNCT03323034
What this trial is testing

Pevonedistat, Irinotecan, and Temozolomide in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphoma

Who this might be right for
Recurrent LymphomaRecurrent Malignant Solid NeoplasmRecurrent Primary Central Nervous System Neoplasm+3 more
Children's Oncology Group 30
Not applicableNo Longer AvailableNCT02187354
What this trial is testing

Expanded Access Protocol - Blinatumomab in Pediatric & Adolescent Subjects With Relapsed/Refractory B-precursor ALL

Who this might be right for
Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia
Amgen
Early research (Phase 1)Study completedNCT01132911
What this trial is testing

A Phase I Study of Vorinostat and Bortezomib in Children With Refractory of Recurrent Solid Tumors, Including CNS Tumors and Lymphomas

Who this might be right for
LymphomaSarcomaWilmsTumor+1 more
National Cancer Institute (NCI) 5
Early research (Phase 1)Ended earlyNCT05077423
What this trial is testing

Trial of CD33xCD3 BsAb in Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
AML, Childhood
Y-mAbs Therapeutics 3
Testing effectiveness (Phase 2)Study completedNCT02422290
What this trial is testing

Ketamine Treatment for Pediatric-Refractory Obsessive-Compulsive Disorder (OCD)

Who this might be right for
Obsessive-Compulsive Disorder
New York State Psychiatric Institute 5
Not applicableLooking for participantsNCT06848582
What this trial is testing

Umbilical Cord Blood NK Cell Therapy for High-Risk Pediatric Soft Tissue Sarcoma: Efficacy and Safety Study

Who this might be right for
Soft Tissue Sarcoma (STS)
Sun Yat-sen University 40
Early research (Phase 1)Study completedNCT03434262
What this trial is testing

SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic EpendymomaAnaplastic Ganglioglioma+53 more
St. Jude Children's Research Hospital 68
Early research (Phase 1)Study completedNCT00002705
What this trial is testing

Topotecan in Treating Children With Refractory Leukemia

Who this might be right for
Leukemia
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)UnknownNCT03654703
What this trial is testing

Improved Post-Transplant Cyclophosphamide Regimens for Pediatric Patients With Refractory AML

Who this might be right for
Hematopoietic System--Cancer
Capital Research Institute of Pediatrics 100
Early research (Phase 1)Looking for participantsNCT07061626
What this trial is testing

Determine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (186Re) in Pediatric Recurrent, Refractory or Progressive Ependymoma and High-Grade Glioma

Who this might be right for
EpendymomaHigh Grade Gliomas
Cerenome 56
Not applicableStudy completedNCT07474415
What this trial is testing

Controlled Trial of Gastric Electrical Stimulation in Children

Who this might be right for
GastroparesisFunctional DyspepsiaVomiting Syndrome
Nationwide Children's Hospital 30
Early research (Phase 1)Looking for participantsNCT07156435
What this trial is testing

Vyxeos® With Clofarabine for Pediatric AML

Who this might be right for
Relapsed Pediatric AMLRefractory Pediatric AML
Princess Maxima Center for Pediatric Oncology 25
Testing effectiveness (Phase 2)Study completedNCT04447755
What this trial is testing

Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080)

Who this might be right for
Relapsed or Refractory Solid Tumors
Merck Sharp & Dohme LLC 127
Testing effectiveness (Phase 2)Looking for participantsNCT07424092
What this trial is testing

Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors

Who this might be right for
High Grade GliomaEpendymomaEmbryonal Tumor of Brain+4 more
Clinica Universidad de Navarra, Universidad de Navarra 39
Testing effectiveness (Phase 2)Ended earlyNCT04145700
What this trial is testing

CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma

Who this might be right for
Synovial Sarcoma
Eli Lilly and Company 23
Next Page